165 related articles for article (PubMed ID: 24052801)
1. Variation of urate transport in the nephrons in subtypes of hyperuricemia.
Nakamura T; Nishi R; Tanaka T; Takagi K; Sakai K; Takai M; Morishima S; Yamauchi T; Ueda T
Nephron Extra; 2013; 3(1):73-85. PubMed ID: 24052801
[TBL] [Abstract][Full Text] [Related]
2. Quantitative estimation of urate transport in nephrons in relation to urinary excretion employing benzbromarone-loading urate clearance tests in cases of hyperuricemia.
Nakamura T; Nishi R; Tanaka T; Takagi K; Yamashita T; Yamauchi T; Ueda T
Nephron Extra; 2011 Jan; 1(1):55-68. PubMed ID: 22470379
[TBL] [Abstract][Full Text] [Related]
3. [Dynamics of uric acid metabolism in hyperuricemia].
Nakamura T; Takagi K; Ueda T
Nihon Rinsho; 1996 Dec; 54(12):3230-6. PubMed ID: 8976097
[TBL] [Abstract][Full Text] [Related]
4. [Historical review of gout and hyperuricemia investigations].
Nakamura T
Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
[TBL] [Abstract][Full Text] [Related]
5. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
[TBL] [Abstract][Full Text] [Related]
6. [Uric acid and arterial hypertension. II. Evaluation of uric acid transport in the nephrons in primary arterial hypertension].
Tykarski A
Pol Arch Med Wewn; 1991 Sep; 86(3):167-76. PubMed ID: 1808601
[TBL] [Abstract][Full Text] [Related]
7. The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor.
Okui D; Sasaki T; Fushimi M; Ohashi T
Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):92-102. PubMed ID: 31734820
[TBL] [Abstract][Full Text] [Related]
8. Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.
Kuriyama S
Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):1-5. PubMed ID: 31754883
[TBL] [Abstract][Full Text] [Related]
9. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.
Matsuo H; Nakayama A; Sakiyama M; Chiba T; Shimizu S; Kawamura Y; Nakashima H; Nakamura T; Takada Y; Oikawa Y; Takada T; Nakaoka H; Abe J; Inoue H; Wakai K; Kawai S; Guang Y; Nakagawa H; Ito T; Niwa K; Yamamoto K; Sakurai Y; Suzuki H; Hosoya T; Ichida K; Shimizu T; Shinomiya N
Sci Rep; 2014 Jan; 4():3755. PubMed ID: 24441388
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion.
Tykarski A
Nephron; 1991; 59(3):364-8. PubMed ID: 1758523
[TBL] [Abstract][Full Text] [Related]
11. Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion.
Yan F; Xue X; Lu J; Dalbeth N; Qi H; Yu Q; Wang C; Sun M; Cui L; Liu Z; He Y; Yuan X; Chen Y; Cheng X; Ma L; Li H; Ji A; Hu S; Ran Z; Terkeltaub R; Li C
Arthritis Rheumatol; 2022 Dec; 74(12):2015-2023. PubMed ID: 35795968
[TBL] [Abstract][Full Text] [Related]
12. Renal handling of urate in a patient with familial juvenile gouty nephropathy.
Hisatome I; Kosaka H; Ohtahara K; Tsuboi M; Manabe I; Ohtahara A; Sawaguchi M; Igawa O; Tanaka Y; Fujimoto Y; Yoshida A; Takeda A; Shigemasa C
Intern Med; 1996 Jul; 35(7):564-8. PubMed ID: 8842764
[TBL] [Abstract][Full Text] [Related]
13. [Effect of total saponin of dioscorea on uric acid excretion indicators in chronic hyperuricemia rats].
Chen GL; Wu S; Na S; Li L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jan; 34(1):75-80. PubMed ID: 24520793
[TBL] [Abstract][Full Text] [Related]
14. Response to febuxostat according to clinical subtypes of hyperuricemia: a prospective cohort study in primary gout.
Qi H; Sun M; Terkeltaub R; Xue X; Li X; Cui L; He Y; Yan F; Sun R; Chen Y; Jia Z; Cheng X; Ma L; Liu T; Dalbeth N; Li C
Arthritis Res Ther; 2023 Dec; 25(1):241. PubMed ID: 38082308
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of benzbromarone versus febuxostat in gouty patients: a retrospective study.
Liu D; Zhou B; Li Z; Zhang Z; Dai X; Ji Z; Chen H; Sun Y; Jiang L
Clin Rheumatol; 2022 Jul; 41(7):2121-2128. PubMed ID: 35229198
[TBL] [Abstract][Full Text] [Related]
16. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats.
Chen X; Ge HZ; Lei SS; Jiang ZT; Su J; He X; Zheng X; Wang HY; Yu QX; Li B; Lv GY; Chen SH
Biomed Pharmacother; 2020 Dec; 132():110765. PubMed ID: 33120237
[TBL] [Abstract][Full Text] [Related]
17. Regulation of uric acid excretion by the kidney.
Lipkowitz MS
Curr Rheumatol Rep; 2012 Apr; 14(2):179-88. PubMed ID: 22359229
[TBL] [Abstract][Full Text] [Related]
18. Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals.
Niu Y; Yang P; Li H; Li Q; Lin H; Gao L; Li L
Biol Pharm Bull; 2020 Nov; 43(11):1653-1659. PubMed ID: 32863294
[TBL] [Abstract][Full Text] [Related]
19. Renal handling of urate in two patients with hyperuricemia and primary hyperparathyroidism.
Hisatome I; Ishimura M; Sasaki N; Yamakawa M; Kosaka H; Tanaka Y; Kouchi T; Mitani Y; Yoshida A; Kotake H
Intern Med; 1992 Jun; 31(6):807-11. PubMed ID: 1392185
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
